Amel Benmahmoud Zoubir

Amel Benmahmoud Zoubir has extensive work experience in the pharmaceutical industry. Amel most recently served as the Head of Medical Affairs for France at Amarin Corporation in 2022. Prior to that, they worked at Bayer Pharmaceuticals as the New Asset & Innovation Medical Lead from 2020 to 2022. From 2019 to 2020, they were a Senior Medical Advisor for Chronic Cough and Endometriosis at MSD France. Before that, they were a Medical Advisor for Women's Health at MSD from 2014 to 2020. Amel also worked as a Medical Science Liaison at MSD France from 2013 to 2014.

Amel Benmahmoud Zoubir completed a post graduation in oncology and obstetrics/gynecology at the Faculty of Medicine de Strasbourg. Amel also earned a doctorate in general medicine from the Faculty of Medicine d'Alger.